Conference Speakers

Srini Akkaraju, M.D., Ph.D.

Founder & Managing Partner

Samsara BioCapital
Srini Akkaraju, M.D., Ph.D. Founder & Managing Partner Samsara BioCapital

Jeremy Caldwell, Ph.D.

Managing Director

Red Tree Venture Capital
Jeremy Caldwell, Ph.D. Managing Director Red Tree Venture Capital

Mira Chaurushiya, Ph.D.

Managing Director

Westlake Village BioPartners
Mira Chaurushiya, Ph.D. Managing Director Westlake Village BioPartners

Alex Cogdill, MEng, Ph.D.

Head of Strategic Initiatives, Global Business Development

Daiichi Sankyo U.S.
Alex Cogdill, MEng, Ph.D. Head of Strategic Initiatives, Global Business Development Daiichi Sankyo U.S.

Richard DiMarchi, Ph.D.

GLP-1 Biology Pioneer; Distinguished Professor & Linda and Jack Gill Chair in Biomolecular Sciences

Indiana University
Richard DiMarchi, Ph.D. GLP-1 Biology Pioneer; Distinguished Professor & Linda and Jack Gill Chair in Biomolecular Sciences Indiana University

Jon Edwards, Ph.D.

Partner

Forbion
Jon Edwards, Ph.D. Partner Forbion

Richard Glynne, Ph.D.

Acting CEO, Belharra Therapeutics; President & CSO, Inception Therapeutics Discovery Engine; Venture Partner

Versant Ventures
Richard Glynne, Ph.D. Acting CEO, Belharra Therapeutics; President & CSO, Inception Therapeutics Discovery Engine; Venture Partner Versant Ventures

Rachna Khosla

Senior Vice President, Business Development

Amgen
Rachna Khosla Senior Vice President, Business Development Amgen

John Lepore, M.D.

CEO, ProFound Therapeutics; CEO-Partner

Flagship Pioneering
John Lepore, M.D. CEO, ProFound Therapeutics; CEO-Partner Flagship Pioneering

Tim Luker, Ph.D.

Vice President, Lilly Ventures, West Coast USA Head, Corp BD

Eli Lilly
Tim Luker, Ph.D. Vice President, Lilly Ventures, West Coast USA Head, Corp BD Eli Lilly

Mathai Mammen, M.D., Ph.D.

Chairman, CEO & President

Parabilis Medicines
Mathai Mammen, M.D., Ph.D. Chairman, CEO & President Parabilis Medicines

Fiona H. Marshall, Ph.D.

President, Biomedical Research

Novartis
Fiona H. Marshall, Ph.D. President, Biomedical Research Novartis

Grace Han McMahon

AVP and Head, Pacific BD&L

Merck
Grace Han McMahon AVP and Head, Pacific BD&L Merck

David Moller

Venture Partner

Third Rock Ventures
David Moller Venture Partner Third Rock Ventures

Nikhil Mutyal, Ph.D.

Head of Search & Evaluation, Respiratory & Immunology

AstraZeneca
Nikhil Mutyal, Ph.D. Head of Search & Evaluation, Respiratory & Immunology AstraZeneca

Deborah Palestrant, Ph.D.

Partner & Executive Chair, 4:59 Initiative

5AM Ventures
Deborah Palestrant, Ph.D. Partner & Executive Chair, 4:59 Initiative 5AM Ventures

Sunil Patel

Head of Corporate Development and Business Development & Licensing

Merck
Sunil Patel Head of Corporate Development and Business Development & Licensing Merck

Andy Plump

President, Research & Development

Takeda Pharmaceutical Company Ltd.
Andy Plump President, Research & Development Takeda Pharmaceutical Company Ltd.

Jeremy Quirk

VP BD&L Commercial Portfolio

GSK
Jeremy Quirk VP BD&L Commercial Portfolio GSK

Peter Schultz, Ph.D.

President, CEO & L.S. “Sam” Skaggs Presidential Chair

Scripps Research
Peter Schultz, Ph.D. President, CEO & L.S. “Sam” Skaggs Presidential Chair Scripps Research

Avi Spier, Ph.D.

Executive Director, Search & Evaluation

Novartis
Avi Spier, Ph.D. Executive Director, Search & Evaluation Novartis

Stephen Squinto

Chief Investment Officer

J.P. Morgan Asset Management
Stephen Squinto Chief Investment Officer J.P. Morgan Asset Management

R. Scott Struthers, Ph.D.

Co-Founder and Chief Executive Officer

Crinetics Pharmaceuticals
R. Scott Struthers, Ph.D. Co-Founder and Chief Executive Officer Crinetics Pharmaceuticals

Marc Tessier-Lavigne, Ph.D.

Co-Founder, Chairman & CEO

Xaira Therapeutics
Marc Tessier-Lavigne, Ph.D. Co-Founder, Chairman & CEO Xaira Therapeutics

Matt Tremblay, Ph.D.

Chief Executive Officer

Blackbird Laboratories
Matt Tremblay, Ph.D. Chief Executive Officer Blackbird Laboratories

Fan Zhang, Ph.D.

Vice President of Business Development

Bristol Myers Squibb
Fan Zhang, Ph.D. Vice President of Business Development Bristol Myers Squibb